|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
|
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash | ||||||||
| Deferred offering costs | ||||||||
| Prepaid expenses | ||||||||
| Total current assets | ||||||||
| Deferred offering costs associated with initial public offering | ||||||||
| Prepaid expenses-non current | ||||||||
| Investments held in trust account | ||||||||
| Total assets | ||||||||
| Liabilities, Redeemable Common Stock and Stockholders' Deficit | ||||||||
| Current liabilities: | ||||||||
| Accrued offering costs and expenses | ||||||||
| Accounts payable and accrued expenses | ||||||||
| Income tax payable | ||||||||
| Working capital loan - related party | ||||||||
| Promissory note - related party | ||||||||
| Due to related party | ||||||||
| Total current liabilities | ||||||||
| Deferred underwriting fee | ||||||||
| Derivative warrant liability | ||||||||
| Total liabilities | ||||||||
| Class A common stock subject to possible redemption, 17,250,000 issued and outstanding at redemption value of $10.04 and $10.00 per share at September 30, 2022 and December 31, 2021, respectively | ||||||||
| Stockholders' Equity (Deficit) | ||||||||
| Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding | ||||||||
| Common stock | ||||||||
| Class A Common Stock | ||||||||
| Class B Common Stock | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated deficit | ||||||||
| Total stockholders' deficit | ||||||||
| Total liabilities and stockholders' deficit |
Loading...
